204 Bibliografia [1] Accordo Stato Regioni 29 del 25 marzo 2021. Accordo, ai sensi dell’articolo 2, comma 1-bis del decreto legislativo 9 novembre 2007 n. 208, così come aggiunto dall’articolo 1, comma 1, lett. b) del decreto legislativo 10 marzo 2018 n.19, tra il Governo, le Regioni e le Province autonome di Trento e di Bolzano sul documento concernente “Aggiornamento e revisione dell’Accordo Stato Regioni 16 dicembre 2010 (rep. atti n. 2421 CSR) sui requisiti minimi organizzativi, strutturali e tecnologici dei servizi trasfusionali e delle unità di raccolta del sangue e degli emocomponenti e sul modello per le visite di verifica. Available at. https:// www.statoregioni.it/it/conferenza-stato-regioni/sedute-2021/seduta-del-25032021/atti/repertorio-atto-n-29-csr/ [2] Società Italiana di Medicina Trasfusionale e Immunoematologia (SIMTI). Standard di Medicina Trasfusionale. SIMTI Ed., I edizione 2017. Disponibile in: https://www.aocz.it/files/Reparti/SIT/ Allegati/Volume_Standard_3%20(1).pdf . ù[3] Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies [Internet]. 7th ed. Cham (CH): Springer; 2019. [4] Velati C, Aprili G. SIMTI recommendations on the correct use of blood components and plasma derivatives. Blood Transfus. 2009 Jan;7(1):1-2. doi: 10.2450/2009.0003-09. [5] Carreau A, El Hafny-Rahbi B, Matejuk A, Grillon C, Kieda C. Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia. J Cell Mol Med. 2011 Jun;15(6):1239-53. doi: 10.1111/j.1582-4934.2011.01258.x. [6] Boveris DL, Boveris A. Oxygen delivery to the tissues and mitochondrial respiration. Front Biosci. 2007 Jan 1;12:1014-23. doi: 10.2741/2121. [7] Giraud C, Thibert JB, Desbrosses Y, Debiol B, Alsuliman T, Bardiaux L, Garban F, Huynh TNP, Samsonova O, Yakoub-Agha I, Bruno B. Transfusion dans l’autogreffe et l’allogreffe de cellules souches hématopoïétiques chez l’adulte et l’enfant : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) [Transfusion in autologous and allogenic hematopoietic stem cell transplant: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. Bull Cancer. 2019 Jan;106(1S):S52-S58. French. doi: 10.1016/j.bulcan.2018.08.016. [8] Lamarche MC, Hammond DE, Hopman WM, Sirosky-Yanyk A, Shepherd L, Bhella SD. Can we transfuse wisely in patients undergoing chemotherapy for acute leukemia or autologous stem cell transplantation? Transfusion. 2019 Jul;59(7):2308-2315. doi: 10.1111/trf.15335. [9] Tay J, Allan DS, Chatelain E, Coyle D, Elemary M, Fulford A, Petrcich W, Ramsay T, Walker I, Xenocostas A, Tinmouth A, Fergusson D. Liberal Versus Restrictive Red Blood Cell Transfusion Thresholds in Hematopoietic Cell Transplantation: A Randomized, Open Label, Phase III, Noninferiority Trial. J Clin Oncol. 2020 May 1;38(13):1463-1473. doi: 10.1200/JCO.19.01836. [10] Estcourt LJ, Malouf R, Trivella M, Fergusson DA, Hopewell S, Murphy MF. Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support. Cochrane Database Syst Rev. 2017 Jan 27;1(1):CD011305. doi: 10.1002/14651858. CD011305.pub2. [11] Società Italiana Talassemie ed Emoglobinopatie (SITE) e Società Italiana Medicina Trasfusionale e Immunoematologia (SIMTI). Raccomandazioni Per le Strategie Trasfusionali nelle Emoglobinopatie. Collana Scientifica SITE N.3. 2014. Available at: https:// www.site-italia.org/ [12] Schiffer CA, Bohlke K, Delaney M, Hume H, Magdalinski AJ, McCullough JJ, Omel JL, Rainey JM, Rebulla P, Rowley SD, Troner MB, Anderson KC. Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2018 Jan 20;36(3):283-299. doi: 10.1200/ JCO.2017.76.1734. [13] Ministero della Salute. Decreto Ministeriale 02 novembre 2015. Disposizioni relative ai requisiti di qualità e sicurezza del sangue e degli emocomponenti. (15A09709) GU Serie Generale n.300 del 28-12-2015 - Suppl. Ordinario n. 69 [14] Aprili G, Bosi A, Lombardini L, Pupella S, Vassanelli A; Italian Society of Transfusion Medicine and Immunohaematology; Italian Group for Bone Marrow Transplantation working group. Recommendations for managing the donation of haematopoietic stem cells from related and unrelated donors for allogeneic transplantation. Blood Transfus. 2013 Apr;11(2):296-304. [15] Italian Bone Marrow Donor Registry. Standard di funzionamento del Programma nazionale Italiano di donazione di Cellule Staminali Emopoietiche da non familiare. Versione XXIV: 3 Agosto 2021. Available at: https://www.ibmdr.galliera.it/ibmdr/standard-ibmdr/standard-ibmdr-versione-2021 [16] Kopolovic I, Ostro J, Tsubota H, Lin Y, Cserti-Gazdewich CM, Messner HA, Keir AK, DenHollander N, Dzik WS, Callum J. A systematic review of transfusion-associated graft-versushost disease. Blood. 2015 Jul 16;126(3):406-14. doi: 10.1182/blood-2015-01-620872. [17] Ljungman P. The role of cytomegalovirus serostatus on outcome of hematopoietic stem cell transplantation. Curr Opin Hematol. 2014 Nov;21(6):466-9. doi: 10.1097/MOH.0000000000000085. [18] Ziemann M, Thiele T. Transfusion-transmitted CMV infection - current knowledge and future perspectives. Transfus Med. 2017 Aug;27(4):238-248. doi: 10.1111/tme.12437. [19] Lieberman L, Devine DV, Reesink HW, Panzer S, Wong J, Raison T, Benson S, Pink J, Leitner GC, Horvath M, Compernolle V, Prado Scuracchio PS, Wendel S, Delage G, Nahirniak S, Dongfu X, Krusius T, Juvonen E, Sainio S, Cazenave JP, Guntz P, Kientz D, Andreu G, Morel P, Seifried E, Hourfar K, Lin CK, O'Riordan J, Raspollini E, Villa S, Rebulla P, Flanagan P, Teo D, Lam S, Ang AL, Lozano M, Sauleda S, Cid J, Pereira A, Ekermo B, Niederhauser C, Waldvogel S, Fontana S, Desborough MJ, Pawson R, Li M, Kamel H, Busch M, Qu L, Triulzi D. Prevention of transfusion -transmitted cytomegalovirus (CMV) infection: Standards of care. Vox Sang. 2014 Oct;107(3):276-311. doi: 10.1111/vox.12103. [20] FACT-JACIE International Standard for Hematopoietic Cellular Therapy, Product Collection, Processing, and Administration.
RkJQdWJsaXNoZXIy ODUzNzk5